NEOCENT: a randomised feasibility and translational study comparing neoadjuvant endocrine therapy with chemotherapy in ER-rich postmenopausal primary breast cancer.
about
Neoadjuvant endocrine therapy in breast cancer: current role and future perspectivesExploring circulating micro-RNA in the neoadjuvant treatment of breast cancerNetwork Meta-Analysis of the Effectiveness of Neoadjuvant Endocrine Therapy for Postmenopausal, HR-Positive Breast Cancer.MiR-17-5p regulates cell proliferation and migration by targeting transforming growth factor-β receptor 2 in gastric cancer.Implementing neoadjuvant endocrine strategies in ER-positive, HER2-negative breast cancer.Neoadjuvant Endocrine Therapy for Estrogen Receptor-Positive Breast Cancer: A Systematic Review and Meta-analysis.Short-term outcomes of neoadjuvant hormonal therapy versus neoadjuvant chemotherapy in breast cancer: systematic review and meta-analysis of randomized controlled trials.Neoadjuvant everolimus plus letrozole versus fluorouracil, epirubicin and cyclophosphamide for ER-positive, HER2-negative breast cancer: study protocol for a randomized pilot trial.Pre-operative Endocrine Therapy.Benefit of the addition of hormone therapy to neoadjuvant anthracycline-based chemotherapy for breast cancer: comparison of predicted and observed pCR.
P2860
Q26773012-4C6D9331-D72A-4F0D-ACBA-E720C920AC1CQ28066481-E7A3ED03-1E15-4E8F-B79E-1474D75FB0D1Q36897982-2243F667-9B93-47B4-9E87-CC7A5EE01040Q37362909-323EA294-E183-49E8-AFB9-C41299AFAEC4Q38765017-0B143984-77E2-46CD-94ED-6C154818224FQ38883281-DABEC44E-A8DF-4323-83B9-5A53F03BE04AQ39167766-399F9D89-0129-4A9E-BA11-38111393443FQ42633783-AD631930-0C07-4669-B28C-0002ACD716FEQ46143861-FB4463F4-C8B5-4EB6-B7C3-4A139A0DA3DAQ48222174-C54B5D80-EC8F-4B2E-A3DA-3DFDFB376E09
P2860
NEOCENT: a randomised feasibility and translational study comparing neoadjuvant endocrine therapy with chemotherapy in ER-rich postmenopausal primary breast cancer.
description
2014 nî lūn-bûn
@nan
2014年の論文
@ja
2014年学术文章
@wuu
2014年学术文章
@zh
2014年学术文章
@zh-cn
2014年学术文章
@zh-hans
2014年学术文章
@zh-my
2014年学术文章
@zh-sg
2014年學術文章
@yue
2014年學術文章
@zh-hant
name
NEOCENT: a randomised feasibil ...... opausal primary breast cancer.
@en
NEOCENT: a randomised feasibil ...... opausal primary breast cancer.
@nl
type
label
NEOCENT: a randomised feasibil ...... opausal primary breast cancer.
@en
NEOCENT: a randomised feasibil ...... opausal primary breast cancer.
@nl
prefLabel
NEOCENT: a randomised feasibil ...... opausal primary breast cancer.
@en
NEOCENT: a randomised feasibil ...... opausal primary breast cancer.
@nl
P2093
P2860
P50
P1476
NEOCENT: a randomised feasibil ...... opausal primary breast cancer.
@en
P2093
A M Thompson
C Palmieri
L Fallowfield
L Primrose
P2860
P2888
P304
P356
10.1007/S10549-014-3183-4
P407
P50
P577
2014-11-14T00:00:00Z